RLAY Sale Disclosure
Patel Sanjiv · SEC Form 4 · Filed Oct 8, 2026
Sale
Calculated transaction value
$872.4K
Patel Sanjiv President And CEO
RLAY
Relay Therapeutics
RLAY
Transaction date
Oct 7, 2026
Public filing date
Oct 8, 2026
Filing lag
Filed 1 day later
RLAY daily price context
Close on/before transaction
$17.95
Oct 7, 2026
First close after public filing
$17.85
Oct 9, 2026
Return after filing · so far
0.0%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 48,199 shares @ $18.1
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-418096
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$872.4K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Relay Therapeutics, Inc. RLAY Current | Sale | Oct 7, 2026 | $872.4K |